Pittsburgh Compound B Unlabelled
Vascular Dementia
National Taiwan University HospitalSmall moleculePhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Vascular Dementia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cilostazol Peking University First Hospital | Phase 4 | BB |
Risperidone Janssen-Cilag Pty Ltd | Phase 3 | BB |
Oxycodone Hydrochloride, Hydrocodone- VA Office of Research and Development | Phase 4 | BB |
Aspirin Peking University First Hospital | Phase 4 | BB |
Rivastigmine Novartis | Phase 3 | BB |
View all 40 →
Same molecule, other indications
Pittsburgh Compound B Unlabelled is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →